Personalizing CLL Treatment Options: Clinical Insights and Strategies to Improve Care

Table of Contents

 
  • Program Overview
    Personalizing CLL Treatment Options: Clinical Insights and Strategies to Improve Care
    This comprehensive program gathers CLL management insights from our distinguished CLL experts and features education on emerging and established treatment strategies enhanced by a decision support tool for individualizing these treatments to your patients. All aspects of this program are designed to complement each other, including the interactive treatment decision aid, expert commentaries, and an expert-authored CME/CE-certified module with downloadable slideset.

Latest Content

1 of 1 Shown
  • How I Use First-Generation vs Second-Generation BTK Inhibitors in CLL and MCL

    John C. Byrd MD - 4/13/2018
    Without comparative data to guide us, how do we decide between recommending ibrutinib or acalabrutinib? Here’s my take on which factors to consider in your patients with CLL or MCL.
1 of 1 Shown
Show 0 More
Loading...